🇺🇸 CI 0.2% ropivacaine in United States

CI 0.2% ropivacaine (CI 0.2% ropivacaine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

CI 0.2% ropivacaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CI 0.2% ropivacaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CI 0.2% ropivacaine in United States?

University Health Network, Toronto is the originator. The local marketing authorisation holder may differ — check the official source linked above.